Financhill
Back

Apellis Pharmaceuticals Vs. Macrogenics Industry Stock Comparison

Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Buy
52

MGNX
Macrogenics

Last Price:
3.24
Seasonality Move:
16.69%
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.77. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Macrogenics (MGNX) is a Buy

Is Macrogenics a Buy, Sell or Hold?

  • The current Macrogenics [MGNX] share price is $3.24. The Score for MGNX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MGNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

MGNX Stock Price Chart

What is Macrogenics's stock price today?

  • The Macrogenics share price today is $3.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 59.23 Buy
Chaikin Money Flow: 2322513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 29.12) Buy
Bollinger Bands (100): (28.55 - 38.61) Sell

MGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 37.78 Sell
Chaikin Money Flow: 57886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 4.09) Sell
Bollinger Bands (100): (3.21 - 4.47) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.97 Buy
20-day SMA: 28.22 Buy
50-day SMA: 29.11 Buy
200-day SMA: 42.36 Sell
8-day EMA: 28.48 Buy
20-day EMA: 28.34 Buy
50-day EMA: 29.88 Buy
200-day EMA: 39.46 Sell

MGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.48 Sell
20-day SMA: 3.73 Sell
50-day SMA: 3.63 Sell
200-day SMA: 8.02 Sell
8-day EMA: 3.47 Sell
20-day EMA: 3.65 Sell
50-day EMA: 3.75 Sell
200-day EMA: 5.92 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Macrogenics Earnings Growth & MGNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.80 per share, and a decrease next year of $1.14 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Macrogenics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):